Show simple item record

AuthorNour El Din, Suzannedc.contributor.author
Date of accession2017-09-13T07:35:59Zdc.date.accessioned
Available in OPARU since2017-09-13T07:35:59Zdc.date.available
Year of creation2016dc.date.created
Date of first publication2017-09-13dc.date.issued
AbstractAzurin is a bacterial protein produced by Pseudomonas aeruginosa with known anticancer properties. A peptide fragment of Azurin (P28) has shown to preferentially enter cancer cells and is responsible for the antitumor effect without affecting neighboring normal cells. We monitored the uptake of EcFbFp (Escherichia coli Flavin mononucleotide binding protein) and the fusion proteins that are composed of P28 and EcFbFp in A549 and MCF7 cells lines. Furthermore, it was investigated the uptake of EcFpFp and the fusion protein using confocal microscopy and western blot. The cytotoxic effect of the combined therapy was assessed using MTT assay. A significant cytotoxic effect (<0.001) was achieved in breast and lung cancer cell lines when treating the cells with the combined therapy in comparison to blue light alone. Also a significant cytotoxic effect was obtained (<0.001) when treating the cells with the fusion proteins compared to EcFbFp. Additionally, the stability of the fusion proteins relative to pH and temperature was assessed. Finally, the amount of ROS (reactive oxygen species) was quantified using H2DCFDA. A significant amount of ROS was observed when treating both cancer cell lines with the fusion proteins and blue light relative to EcFbFp or blue light alone. Here, we propose a new photosensitizer to be used in the photodynamic therapy. This photosensitizer has the ability to target cancer cell and exert a site-specific cytotoxic effect.dc.description.abstract
Languageendc.language.iso
PublisherUniversität Ulmdc.publisher
LicenseStandarddc.rights
Link to license texthttps://oparu.uni-ulm.de/xmlui/license_v3dc.rights.uri
KeywordPhotodynamic therapydc.subject
KeywordBreast cancerdc.subject
KeywordLOVdc.subject
KeywordEcFbFpdc.subject
KeywordAzurindc.subject
KeywordP28dc.subject
Dewey Decimal GroupDDC 610 / Medicine & healthdc.subject.ddc
MeSHBreast neoplasms; Therapydc.subject.mesh
MeSHLung neoplasms; Therapydc.subject.mesh
MeSHPhotochemotherapydc.subject.mesh
MeSHPhotosensitizing agentsdc.subject.mesh
MeSHReactive oxygen speciesdc.subject.mesh
TitleAzurin (P28) fusion protein mediated photodynamic therapy in the treatment of malignant tumorsdc.title
Resource typeDissertationdc.type
Date of acceptance2017-06-23dcterms.dateAccepted
RefereeRosenau, Frankdc.contributor.referee
RefereeWeil, Tanjadc.contributor.referee
DOIhttp://dx.doi.org/10.18725/OPARU-4510dc.identifier.doi
PPN165564274Xdc.identifier.ppn
URNhttp://nbn-resolving.de/urn:nbn:de:bsz:289-oparu-4549-7dc.identifier.urn
GNDFotodynamische Therapiedc.subject.gnd
GNDAzurinedc.subject.gnd
FacultyFakultät für Naturwissenschaftenuulm.affiliationGeneral
InstitutionKompetenzzentrum "Ulm Peptide Pharmaceuticals (U-PEP)"uulm.affiliationSpecific
Shelfmark print versionW: W-H 15.278uulm.shelfmark
Grantor of degreeFakultät für Naturwissenschaftenuulm.thesisGrantor
DCMI TypeTextuulm.typeDCMI
TypeErstveröffentlichunguulm.veroeffentlichung
CategoryPublikationenuulm.category


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record